2019). However, these treatments are causing concerns related to the long-lasting persistence of copper in the environment with the consequent toxic effects toward plants, animals and soil microbiota, and related to the contamination of food (Abbate et al. 2019; El Boumlasy et al. 2022). In...
Perspectives on Engineered Nanoparticles for Cancer TherapyBiofilms at InterfacesBiomaterial Modifications and Improvement of Their Biocompatibility 2.0Bone Cells and Related InteractionsCholesterol Metabolism in Cancers and Therapeutic InnovationsDevelopment of Gene Therapy for Age-Related Macular-Degeneration (AMD)...
The redesigned “Home” page retains the familiar design, but it’s been updated to use the Windows UI Library (WinUI) framework. Also, the “Quick Access” folders (for Microsoft accounts), “Favorites,” and “Recent” sections are getting visual treatments using the same framework. On devi...
This breakthrough promises to advance basic research and drug discovery, enabling more effective treatments and preventive strategies. Future AI-driven tools for protein structure prediction are expected to streamline early-stage drug development, optimize preclinical trials, facilitate drug repurposing, and...
"We believe this is incredibly important and timely for several reasons. First, since 2014, there have been several groundbreaking clinical trials in prevention treatments, particularly with GLP-1 receptor agonists. These have been shown not only to significantly improve diabetes control...
To use lignocellulosic biomass as a raw material, different treatments are required for its solubilization. Currently, efficient treatments to facilitate the use of this material are generally based on chemical compounds that cause environmental contamination2; thus, xylanases has been used for the ...
G protein-coupled receptors (GPCRs) widely exist in vivo and participate in many physiological processes, thus emerging as important targets for drug development. Approximately 30% of the Food and Drug Administration (FDA)-approved drugs target GPCRs. To
ProfessorGregor Wenning, Chair of the Division of Neurobiology at Medical University of Innsbruck and Co-Founding Director of the European MSA Study Group, said: "There is a great need for new treatments of this devastating condition. The exceptional work from Dr. Stefanova's team demonstrates the...
For example, it can improve patient access to enhanced mammography and magnetic resonance imaging–based screening10 or allow a better tailoring of radiotherapy treatments to patients with cancer.7,11 In this context, it is of paramount relevance to accurately assess the deleterious effect of ...
The advent of highly effective treatments targeting the disease biology of chronic lymphocytic leukemia (CLL) has transformed the therapeutic field tremendously. However, transformation into an aggressive B-cell lymphoma, called Richter syndrome (RS), remains highly challenging since the treatment options ...